KVUE's stock performance has suffered from legacy investor selling, management turnover, litigation risks, and a profit ...

This was the stock's second consecutive day of gains.

One of the common rationales of any M&A deal is that the combined enterprise will generate a higher growth rate and perform ...

Kenvue (KVUE) keeps drifting lower even after reporting steady revenue and profit growth, which raises a simple question for ...

In 2025, Paxton filed lawsuits against Tylenol manufacturers Johnson & Johnson and Kenvue, Roblox Corporation and the U.S.

This was the stock's second consecutive day of losses.

Add in the steady cash returns from dividend stocks, and you can further increase your potential total returns. With this in ...

Kenvue has a lower P/E than the aggregate P/E of 55.57 of the Personal Products industry. Ideally, one might believe that the ...

"I will not allow Big Pharma to operate above the law or put their greed ahead of Texans’ well-being," said Paxton.

Kimberly-Clark is acquiring Kenvue, creating a health and wellness giant with $32 billion in revenue and 10 brands generating ...

Attorney General Paxton secured a court order against Johnson & Johnson and Kenvue for operating without proper registration ...

A Texas judge has ordered Tylenol-maker Kenvue Inc. and its former parent Johnson & Johnson to register with the Texas Secretary of State or risk being barred from doing business in the state.